X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Syntegon supplies pharma packaging lines to Pharmax in Dubai

Content Team by Content Team
24th January 2020
in Packaging & Logistic, Press Statements
Syntegon supplies pharma packaging lines to Pharmax in Dubai

Pharmax was set up to help the UAE become more independent from imported drugs and promote the local production of generic pharmaceuticals.

With a recent requirement of mandatory health insurance for all residents, the pharmaceutical and healthcare market in the UAE is growing at a rapid pace.

The UAE Government is now strongly supporting local manufacturers to produce locally and provide the growing market with affordable equivalent medications.

The custom-built factory is equipped with the latest technology, meeting European, UAE and GMP standards.

The facility received its GMP license in March 2018 and is now producing with an annual capacity of over 200 million tablet and capsule dosage forms.

Pharmax ordered a number of different machines required for the Oral Solid Dosage (OSD) formulation plant.

The Syntegon Technology subsidiary Huettlin supplied a granulation line consisting of a Pilotmix high-shear granulator and a Pilotlab unit for optional coating in the fluid bed with a capacity range of between 15 and 60 kilograms for water-based and solvent products.

The tablets are pressed on a TPR 200, which is designed for small to medium batches. The machine can achieve an output of more than 230,000 tablets per hour. An XL Coater Lab 02 is used for tablet coating.

Further equipment includes a capsule filling and closing machine GKF 702, featuring a capsule deduster with integrated metal detector.

The GKF 702 can process between 3,000 and 42,000 capsules per hour and is suited for research and development as well as in production scale operations. With the technologies from Syntegon Technology, Pharmax covers a large part of the OSD development and production process.

Madhukar Tanna, chief executive of Pharmax, said: “When we started planning our new production, highest quality and technical support were key for us.

“Since a number of employees, including myself already had experience with Syntegon Technology, we knew about their unrivalled quality and technical support. This made the decision very easy for us.”

Previous Post

World Courier and ICS Become First End-to-End Specialty Logistics Provider for Advanced Therapies

Next Post

Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Related Posts

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Europe

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

3rd March 2023
Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero
Manufacturing

Canada’s National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

22nd February 2023
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
News

DoKaSch Temperature Solutions and ANA sign master rental agreement

21st February 2023
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine
Drug Development

Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China

21st February 2023
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
Clinical Trials

Labcorp Unveils New Name for Future Independent Clinical Development Business – Fortrea

21st February 2023
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
IPR Data Management

Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

21st February 2023
Next Post
Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In